Dr. Howard L. Ritter practices Hematology. He went to medical school at University of Toledo College of Medicine. He received awards:"Meaningful Use Stage 1 Certification". Howard L. Ritter, MD is also a published physician. He has 2 paper published. The most recent paper is: A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and/or poor performance non-small cell lung cancer patients (N01C9). He is registered with Medicare.
|
Dr. Timothy C. Kasunic, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. Iman Mohamed, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Roland T. Skeel, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. Nasfat J. Shehadeh, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. Bahu S. Shaikh, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Cecilia Choi, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Andrew J. Britton, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. Thomas E. Downs, MD
|
|
Dr. Paul L. Schaefer, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Gregory M. Prince, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Mary R. Smith, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Charu L. Trivedi, MD
This Doctor is OpenDoctor Recommended.
|